Transgene Biotek Balance Sheet Annual

BSE: - | NSE: - | ISIN: - | Sector: -

2.17 +0.06 (2.84%)Updated : 11 Feb 2026

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Liabilities Shareholders' Equity	144.09	142.33	142.36	147.10
Cash Equivalents	0.02	0.00	0.00	0.01
Other Liabilities Total	115.22	115.40	115.57	115.75
Long Term Debt	6.10	5.08	4.95	4.77
Common Stock Total	75.77	75.77	75.77	75.77
Other Current Assets Total	0.94	1.06	1.00	0.58
Total Assets	144.09	142.33	142.36	147.10
Cash	0.26	0.01	0.00	0.01
Total Equity	10.03	10.71	11.37	17.38
Long Term Investments	0.10	0.10	0.10	0.10
Retained Earnings( Accumulated Deficit)	-65.74	-65.06	-64.40	-58.39
Total Common Shares Outstanding	7.58	7.58	7.58	7.58
Tangible Book Valueper Share Common Eq	0.46	0.55	0.63	0.79
Total Liabilities	134.06	131.62	130.99	129.72
Total Debt	14.52	14.00	13.11	12.01
Cashand Short Term Investments	0.28	0.01	0.00	0.02
Total Receivables Net	0.01	0.01	0.01	0.01
Notes Payable/ Short Term Debt	8.42	8.92	8.16	7.24
Accounts Receivable- Trade Net	0.01	0.01	0.01	0.01
Property/ Plant/ Equipment Total- Net	3.29	1.67	1.76	1.85
Total Current Liabilities	12.74	11.14	10.47	9.21
Total Inventory	0.03	0.03	0.03	0.09
Accounts Payable	1.59	0.20	0.23	0.20
Other Currentliabilities Total	2.73	2.02	2.08	1.76
Total Long Term Debt	6.10	5.08	4.95	4.77
Intangibles Net	6.55	6.55	6.56	11.42
Other Long Term Assets Total	0.00	-	0.00	0.14
Note Receivable- Long Term	132.90	132.90	132.90	132.90
period Length	0.00	0.00	0.00	0.00
Total Current Assets	1.26	1.11	1.04	0.70